AIDS-linked tumors are predicted to decline by 2030.
Researchers believe arsenic exposure might contribute to higher-than-normal rates of bladder cancer in the region.
Many cancer types continue to experience a steady rate drop, but there's been a concerning increase in liver cancer.
Differences in Cancer Rates Seen Among Asian American and Native Hawaiian/Pacific Islander PopulationsJanuary 29, 2016
Significant differences in cancer rates were found between Asian Americans and Native Hawaiians/Pacific Islanders (AANHPIs), according to a special report within Cancer Facts & Figures 2016.
HPV-positive oropharyngeal cancer prevalence varies between Western Europe and Eastern Europe, according to study data.
The cancer death rate has dropped by 23% since its peak in 1991, averting more than 1.7 million cancer deaths through 2012, with advances in cancer prevention, early detection, and treatment a part of this rate decline.
Generally, indigenous cancer rates are lower, except for lung cancer in men and cervical cancer in women.
Variations in cancer risk are likely due to differences in exposure to carcinogens, screening rates, and lifestyle factors.
Areas of the U.S. with higher colorectal cancer rates include parts of the Mississippi Delta, Appalachia, and eastern Virginia.
New diagnoses of prostate cancer have declined in the U.S. following the 2011 USPSTF draft recommendation regarding the use of prostate-specific antigen (PSA)-based screenings.
The rate of esophageal cancer rates in men have climbed radically since the 1980s, according to new statistics from Cancer Research UK.
Research suggests that over the last 20 years colorectal cancer (CRC) rates been increasing among young and early middle-aged American adults.
Airline pilots and cabin crew have an increased incidence of melanoma, nearly twice that of the general population, according to a meta-analysis published online.
A new analysis confirms that US lung cancer rates are declining overall, but it also uncovers previously unrecognized trends related to cancer subtype, sex, race/ethnicity, and age.
Sign Up for Free e-newsletters
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- American Association for Cancer Research Releases Its 2018 Annual Report
- Pulmonary Toxicity Increased in Pediatric Hodgkin Lymphoma Treated With Brentuximab Vedotin
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Skin Cancer Screening: Are They Effective?
- Metronidazole, Vancomycin Recommended for C Difficile in Pediatric Oncology, HSCT
- CDC: HPV Vaccination Rates on the Rise Among Adolescents
- High-Dose vs Standard-Dose Flu Vaccine in Elderly Receiving Chemotherapy
- FDA Grants Approval to Novel Treatment for Hairy Cell Leukemia
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|